Ophthalmic Plastic and Reconstructive Surgery · Roanoke, VA
NPI
1104008226
Since 2007
Specialty
Ophthalmic Plastic and Reconstructive Surgery
Code 207WX0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
707 S Jefferson St
Roanoke, VA, 24016
Phone (540) 344-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$417K
25,425 services
Medicare patients, 2024
1,124
Average age 76
Drug cost, 2024
$1.7M
1,665 prescriptions
Company payments, 2025
$502
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas A Ramey was code J0585 (injection, onabotulinumtoxina, 1 unit), 19,643 times for 117 patients. In total Nicholas A Ramey billed 25,425 services in 87 codes, and Medicare paid $417K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 19,643 | 117 | $4.86 | $95K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 2,831 | 19 | $4.08 | $12K |
| 92285 Standard X-ray | Office | 717 | 696 | $15.56 | $11K |
| 99213 Office E&M - Established | Office | 607 | 540 | $59.49 | $36K |
| 64612 Musculoskeletal | Office | 339 | 122 | $109.05 | $37K |
| 99214 Office E&M - Established | Office | 224 | 217 | $86.97 | $19K |
| 99204 Office E&M - New | Office | 156 | 156 | $113.89 | $18K |
| 92082 Vision, Hearing, and Speech Services | Office | 113 | 113 | $34.40 | $3,887 |
| 99203 Office E&M - New | Office | 78 | 78 | $70.10 | $5,468 |
| 67840 Eye | Office | 62 | 62 | $210.96 | $13K |
| 15823 Skin | Facility | 57 | 57 | $620.35 | $35K |
| 11440 Skin Lesion Excision | Office | 50 | 25 | $71.67 | $3,584 |
| 67904 Eye | Facility | 44 | 44 | $621.12 | $27K |
| 68840 Eye | Office | 40 | 40 | $124.90 | $4,996 |
| 67820 Eye | Office | 33 | 21 | $12.19 | $402 |
By year: 2022 $446K for 26,027 services; 2023 $409K for 22,282 services; 2024 $417K for 25,425 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas A Ramey prescribed most often to Medicare patients was Erythromycin (Erythromycin Base), with 725 prescriptions and refills. In total Nicholas A Ramey wrote 1,665 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Erythromycin Erythromycin Base | 725 | 733 | 472 | $6,678 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 239 | 239 | 229 | $1,195 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 144 | 149 | 97 | $1,331 |
| Cephalexin Generic | 136 | 136 | 127 | $524 |
| Bacitracin-Polymyxin Bacitracin/Polymyxin B Sulfate | 97 | 103 | 63 | $1,167 |
| Doxycycline Hyclate Generic | 47 | 57 | 36 | $749 |
| Clindamycin Hcl Generic | 36 | 36 | 34 | $133 |
| Tepezza Teprotumumab-Trbw | 32 | 32 | Under 11 | $1.7M |
| Moxifloxacin Moxifloxacin Hcl | 22 | 23 | 11 | $420 |
| Ciprofloxacin Hcl Generic | 16 | 17 | Under 11 | $201 |
| Atropine Sulfate Generic | 14 | 17 | Under 11 | $469 |
| Tramadol Hcl Generic | 12 | 12 | 12 | $22.48 |
| Doxycycline Monohydrate Generic | 12 | 18 | Under 11 | $92.77 |
| Sodium Chloride 0.9 % Sodium Chloride | 11 | 11 | Under 11 | $29.49 |
| Ondansetron Odt Ondansetron | 11 | 11 | 11 | $159 |
Brand drugs: 125 claims; generic drugs: 1,540 claims; opioid claims: 262.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas A Ramey $502 ($502 in general payments such as food, travel and fees) from 6 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $210.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.